Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Lipitor OTC Bid Would Face An FDA Evolving On Switch Innovation

Mar 12 2014

• By Malcolm Spicer

Related Content

FDA Advisors Say Greater Insight Needed On Self-Selection Of OTC Statins

Dec 17 2007

Pfizer Will Delay <em>Lipitor</em> Switch Until Rx Revenues Fade

Nov 07 2011

Statin Label Change Stirs OTC Switch Discussions

Mar 05 2012

FDA Encourages Novel Switch Ideas, Though NSURE Remains Unsure

Nov 07 2013

Related Companies

Pfizer Inc.

Merck & Co., Inc.

Bayer AG

AstraZeneca PLC

Merck & Co., Inc.

Additional Topics

United States Business Strategies Launches Manufacturing Innovation Prescription To OTC Switch Drug Approval Standards Compliance Regulation Advisory Committees OTC Drugs BioPharmaceutical Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window